Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113096923 | 11309692 | 3 | F | 20150513 | 20160719 | 20150724 | 20160722 | EXP | PHHY2015PT059665 | NOVARTIS | 53.00 | YR | F | Y | 0.00000 | 20160722 | MD | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113096923 | 11309692 | 1 | PS | EXTAVIA | INTERFERON BETA-1B | 1 | Unknown | 250 UG/ML, UNK | U | 125290 | |||||||||
| 113096923 | 11309692 | 2 | C | PARKADINA | 2 | Unknown | U | 0 | |||||||||||
| 113096923 | 11309692 | 3 | C | FOLICIL | FOLIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 113096923 | 11309692 | 4 | C | ELONTRIL | BUPROPION HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 113096923 | 11309692 | 5 | C | PERMADOZE | 2 | Unknown | U | 0 | |||||||||||
| 113096923 | 11309692 | 6 | C | VIGANTOL//COLECALCIFEROL | 2 | Unknown | U | 0 | |||||||||||
| 113096923 | 11309692 | 7 | C | BIALZEPAM | 2 | Unknown | U | 0 | |||||||||||
| 113096923 | 11309692 | 8 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 113096923 | 11309692 | 9 | C | CAPTOPRIL. | CAPTOPRIL | 1 | Unknown | UNK UNK, PRN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113096923 | 11309692 | 1 | Multiple sclerosis |
| 113096923 | 11309692 | 2 | Product used for unknown indication |
| 113096923 | 11309692 | 3 | Product used for unknown indication |
| 113096923 | 11309692 | 4 | Product used for unknown indication |
| 113096923 | 11309692 | 5 | Product used for unknown indication |
| 113096923 | 11309692 | 6 | Product used for unknown indication |
| 113096923 | 11309692 | 7 | Product used for unknown indication |
| 113096923 | 11309692 | 8 | Product used for unknown indication |
| 113096923 | 11309692 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113096923 | 11309692 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113096923 | 11309692 | Blood pressure fluctuation | |
| 113096923 | 11309692 | Blood pressure increased | |
| 113096923 | 11309692 | Dizziness | |
| 113096923 | 11309692 | Dry skin | |
| 113096923 | 11309692 | Headache | |
| 113096923 | 11309692 | Hypoaesthesia | |
| 113096923 | 11309692 | Injection site mass | |
| 113096923 | 11309692 | Injection site pruritus | |
| 113096923 | 11309692 | Memory impairment | |
| 113096923 | 11309692 | Multiple sclerosis relapse | |
| 113096923 | 11309692 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |